Funding Opportunities

NJ ACTS funding programs accelerate clinical and translational science to develop new therapies and treatments and improve healthcare.

NJ ACTS Funding Opportunities

Pilot Grant Awards

BERD Mini-Methods Grants

TL1 Fellowship Training Awards

KL2 Mentored Career Development Awards

Community Core – Partnership and Innovation Accelerator Pilot (PIAP) Program

COVID-19 Funding Opportunities

NEW! Apply for a RADx-UP Coordination and Data Collection Center Grant
To further support communities across the nation who are confronting COVID-19, the RADx-UP Coordination and Data Collection Center (CDCC) is soliciting applications for two kinds of awards:

The RADx-UP CDCC Community Collaboration Mini-Grant Program provides $50,000 for direct costs and is open to community-serving organizations, faith-based organizations, and tribal nations and organizations to help advance capacity, training, support, and community experience with COVID-19 testing initiatives.
The RADx-UP CDCC Rapid Research Pilot Program provides $200,000 in direct costs to support the implementation of novel or emerging testing technologies in communities. This opportunity is open to universities and non-profits both within and outside of the RADx-UP network.

Letter of Interest due: November 19, 2021
Full application due: December 10, 2021

Covid-19 Funding Opportunities Page

Rutgers Research Portal

Rutgers Research Portal – COVID-19 Specific Opportunities

Rutgers COVID-19 Featured Funding Opportunities

Weekly NIH Funding Opportunities and Notices LISTSERV

CTSA Notices and Administrative Supplements

Due Date	Title
9/24/21	NJ ACTS Diversity and Re-entry/Re-integration Supplements for Junior Faculty (Instructor and Assistant Professor) PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PA-21-071.html NOT-OD-21-134: Notice of Special Interest (NOSI): Research Supplements to Promote Reentry and Re-integration into Health-Related Research Careers (Admin Supp – Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-134.html
11/1/21	New Notice of Special Interest (NOSI) NOT-OD-21-134: Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers. For investigators developing independent research careers this supplement will provide up to and no more than $100,000/year for salary, plus fringe benefits. See terms and conditions in the FOA. For questions, contact Jamie Mihoko Doyle, PhD (jamie.doyle@nih.gov)
	NEW: Funding Opportunity Announcements for RADx-UP Phase II. RFA-OD-21-008 Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations- RADx-UP Phase II (U01, Clinical Trial Optional). More information. RFA-OD-21-009 – Emergency Award: RADx-UP – Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional). More information. NOT-OD-21-103 – Notice of Special Interest (NOSI): Emergency Competitive Revisions for NIH Grants to Add or Expand Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement- Clinical Trial Optional). More information. NOT-OD-21-101– Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake. More information.

Due Date

Title

9/24/21

NJ ACTS Diversity and Re-entry/Re-integration Supplements for Junior Faculty (Instructor and Assistant Professor)

PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PA-21-071.html

NOT-OD-21-134: Notice of Special Interest (NOSI): Research Supplements to Promote Reentry and Re-integration into Health-Related Research Careers (Admin Supp – Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-134.html

11/1/21

New Notice of Special Interest (NOSI) NOT-OD-21-134: Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers. For investigators developing independent research careers this supplement will provide up to and no more than $100,000/year for salary, plus fringe benefits. See terms and conditions in the FOA. For questions, contact Jamie Mihoko Doyle, PhD (jamie.doyle@nih.gov)

NEW: Funding Opportunity Announcements for RADx-UP Phase II.

RFA-OD-21-008 Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations- RADx-UP Phase II (U01, Clinical Trial Optional). More information.
RFA-OD-21-009 – Emergency Award: RADx-UP – Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional). More information.
NOT-OD-21-103 – Notice of Special Interest (NOSI): Emergency Competitive Revisions for NIH Grants to Add or Expand Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement- Clinical Trial Optional). More information.
NOT-OD-21-101– Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake. More information.

Additional Funding Sources

Organization	Description
NEW – Rutgers Research – Featured Funding Opportunities	Explore a wide range of curated internal and external funding opportunities to help advance your research and scholarly activities.
Rutgers Office of Research and Economic Development (ORED)	ORED provides a pipeline of services across Rutgers to drive and support faculty research and strategically leads the university’s economic development activities.
Rutgers BHI-RUN-NJIT Pilot Grants in Neuroscience Program	A joint effort by Rutgers Brain Health Institute and New Jersey Institute of Technology, that funds interdisciplinary pilot studies to test new ideas in translational neuroscience and obtain preliminary data to allow funding from external sources.
Charles and Johanna Busch Biomedical Grant Awards	These grants, available to RBHS faculty and their collaborators, are designed to enhance health-related research and strengthen competitive position of faculty members to seek external funds.
Patient-Centered Outcomes Research Institute (PCORI)	High-quality comparative effectiveness research (CER) projects that will examine a critical patient-centered research question that is also relevant to decision makers and other stakeholders.
HEAL Initiative: Pain Management Effectiveness Research Network	The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis.
NIH INCLUDE Project	The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) project calls for a new trans-NIH research initiative on critical health and quality-of-life needs for individuals with Down syndrome.
TechAdvance	Offers grants of up to $100,000 for promising technologies in areas including life science, physical science, engineering, agriculture and IT that have strong potential for commercial success but are “too early” for investors or industry partners.
Rutgers I-Corps Site	Provides training, resources, networking opportunities, and modest funding to assist in transitioning innovations into the marketplace. Students, faculty, and staff from all Rutgers campuses are eligible to apply.
NIH Loan Repayment Programs (LRPs)	A set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers.
NHLBI Catalyze Program Current Funding Opportunties	The NHLBI Catalyze Program facilitates the transition of basic science discoveries into viable diagnostic and therapeutic candidates cleared for human testing.

Citing the CTSA Grant

Please go to the Cite the CTSA page.